2024
DOI: 10.3390/pharmaceutics16020177
|View full text |Cite
|
Sign up to set email alerts
|

Recent Trends in Curcumin-Containing Inorganic-Based Nanoparticles Intended for In Vivo Cancer Therapy

Douglas Dourado,
Júlio Miranda,
Matheus de Oliveira
et al.

Abstract: Curcumin is a natural compound that has been widely investigated thanks to its various biological properties, including antiproliferative. This molecule acts on different cancers such as lung, breast, pancreatic, colorectal, etc. However, the bioactive actions of curcumin have limitations when its physicochemical properties compromise its pharmacological potential. As a therapeutic strategy against cancer, curcumin has been associated with inorganic nanoparticles. These nanocarriers are capable of delivering c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 104 publications
0
2
0
Order By: Relevance
“…[ 1 ]. In particular, nano-sized drug delivery systems have been extensively investigated because of their outstanding properties such as good stability and high drug load and their feasibility of incorporating both hydrophobic and hydrophilic molecules, as well as various drug administration routes (inhalation, oral, topical, and parenteral injection) [ 1 , 2 , 3 , 4 , 5 , 6 ]. Moreover, nanocarriers enable to improve the drug bioavailability, to diminish the dosing frequency, to reduce the side effects, and to achieve targeted drug delivery [ 7 , 8 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[ 1 ]. In particular, nano-sized drug delivery systems have been extensively investigated because of their outstanding properties such as good stability and high drug load and their feasibility of incorporating both hydrophobic and hydrophilic molecules, as well as various drug administration routes (inhalation, oral, topical, and parenteral injection) [ 1 , 2 , 3 , 4 , 5 , 6 ]. Moreover, nanocarriers enable to improve the drug bioavailability, to diminish the dosing frequency, to reduce the side effects, and to achieve targeted drug delivery [ 7 , 8 ].…”
Section: Introductionmentioning
confidence: 99%
“…Hybrid nanocarriers have also been designed to take advantage of both polymers and inorganic materials [ 15 ]. Similarly, inorganic nanoparticles have been prepared to deliver drugs to the tumor site to improve drug effectiveness [ 5 ]. Nevertheless, polymeric drug delivery systems have attracted more attention because their sizes, geometries, surface properties, and structures can be tailored by varying the chemical composition and topology of the polymers which compose the systems [ 16 ].…”
Section: Introductionmentioning
confidence: 99%